Progesterone,Estrogens,and their Receptors in Breast Cancers KATHRYN B. HORWITZ,Departments of Medicine,Pathology and the Molecular Biology Program,University of Colorado School of Medicine,Denver,Colorado
Free accessResearch articleFirst published online January, 2004
Progesterone,Estrogens,and their Receptors in Breast Cancers KATHRYN B. HORWITZ,Departments of Medicine,Pathology and the Molecular Biology Program,University of Colorado School of Medicine,Denver,Colorado
Hopp, T.A., H.L. Weiss, V.-J. Bardou, S.G. Hilsenbeck, D.C. Allred, K.B. Horwitz, and S.A.W. Fuqua (Submitted). “Progesterone Receptor (PR) A and B in Breast Cancer: PR-A Rich Tumors Have Poorer Disease Free Survival.”
2.
Jacobsen, B.M., S. Schittone, J.K. Richer, and K.B. Horwitz (2002). “Construction of New Breast Cancer Cell Lines with Inducible Progesterone A-and B-Receptors: Ligand Independent Effects and Isoform Ratios. J Biol Chem277(31): 27793—800.
3.
Richer, J.K., B.M. Jacobsen, N.G. Manning, M.G. Abel, D.M. Wolf, and K.B. Horwitz (2002). “Differential Gene Regulation by the two Progesterone Receptor Isoforms in Human Breast Cancer Cells.” J Biol Chem277(7): 5209—18.
4.
Sartorius, C.A., T. Shen, and K.B. Horwitz (2003). “Progesterone A Receptors Repress the Growth of Estrogen-Dependent Human Breast Tumor Xenografts.” Breast Cancer Res and Treatment79: 287—99.
5.
Tung, L., C.A. Sartorius, M.G. Abel, T. Shen, G.S. Takimoto, and K.B. Horwitz (2001). “Mapping the Progesterone B-receptor N-terminal Upstream Segment (BUS) Involved in Activation Function-3. Two LXXLL Motifs and a Conserved Tryptophan are Required for Activity.” J Biol Chem276(43): 39843—51.
